DK0789589T3 - Sammensætning, anordning og fremgangsmåde til elektrotransport-middeltilförsel - Google Patents

Sammensætning, anordning og fremgangsmåde til elektrotransport-middeltilförsel

Info

Publication number
DK0789589T3
DK0789589T3 DK95941347T DK95941347T DK0789589T3 DK 0789589 T3 DK0789589 T3 DK 0789589T3 DK 95941347 T DK95941347 T DK 95941347T DK 95941347 T DK95941347 T DK 95941347T DK 0789589 T3 DK0789589 T3 DK 0789589T3
Authority
DK
Denmark
Prior art keywords
composition
body surface
electrotransport
agent supply
applying
Prior art date
Application number
DK95941347T
Other languages
English (en)
Inventor
James A Huntington
Michel Cormier
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0789589T3 publication Critical patent/DK0789589T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Centrifugal Separators (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
DK95941347T 1994-11-14 1995-11-01 Sammensætning, anordning og fremgangsmåde til elektrotransport-middeltilförsel DK0789589T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/338,924 US5736580A (en) 1994-11-14 1994-11-14 Composition, device, and method for electrotransport agent delivery
PCT/US1995/014091 WO1996014869A1 (en) 1994-11-14 1995-11-01 Composition, device, and method for electrotransport agent delivery

Publications (1)

Publication Number Publication Date
DK0789589T3 true DK0789589T3 (da) 2007-12-17

Family

ID=23326715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95941347T DK0789589T3 (da) 1994-11-14 1995-11-01 Sammensætning, anordning og fremgangsmåde til elektrotransport-middeltilförsel

Country Status (11)

Country Link
US (3) US5736580A (da)
EP (1) EP0789589B1 (da)
JP (1) JP4049389B2 (da)
AT (1) ATE369150T1 (da)
CA (1) CA2201725C (da)
DE (1) DE69535556T2 (da)
DK (1) DK0789589T3 (da)
ES (1) ES2292171T3 (da)
HK (1) HK1000450A1 (da)
PT (1) PT789589E (da)
WO (1) WO1996014869A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) * 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US8321013B2 (en) * 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． 電気的筋肉制御装置
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6119036A (en) * 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
CA2308489A1 (en) 1997-10-09 1999-04-22 Emory University Method and devices for transdermal delivery of lithium
EP0922467A3 (en) * 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretic drug delivery
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8019421B2 (en) * 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6477410B1 (en) * 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
DE19923427A1 (de) 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
US7171263B2 (en) * 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US7092753B2 (en) * 1999-06-04 2006-08-15 Impulse Dynamics Nv Drug delivery device
US7190997B1 (en) 1999-06-04 2007-03-13 Impulse Dynamics Nv Drug delivery device
US7069226B1 (en) 1999-07-07 2006-06-27 Synetic, Incorporated Prescription data processing system for determining new therapy starts
EP1246792B1 (en) * 2000-01-13 2014-08-13 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
ATE359802T1 (de) * 2002-10-04 2007-05-15 Photokinetix Inc Photokinetische abgabe von biologisch aktiven subtanzen unter verwendung von pulsierendem inkohaerentem licht.
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
EP1827571B1 (en) 2004-12-09 2016-09-07 Impulse Dynamics NV Protein activity modification
US8296162B1 (en) 2005-02-01 2012-10-23 Webmd Llc. Systems, devices, and methods for providing healthcare information
WO2006097934A2 (en) 2005-03-18 2006-09-21 Metacure Limited Pancreas lead
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
US8380530B2 (en) 2007-02-02 2013-02-19 Webmd Llc. Personalized health records with associative relationships
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US20090137925A1 (en) * 2007-11-23 2009-05-28 Divya Cantor Impedance Spectroscopy Cervix Scanning Apparatus and Method
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
WO2011046927A1 (en) * 2009-10-13 2011-04-21 Nupathe,Inc. Transdermal methods and systems for the delivery of rizatriptan
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
JP6243102B2 (ja) * 2012-05-01 2017-12-06 株式会社ジェムインターナショナル 貼付剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084241A (en) * 1982-09-20 1992-01-28 V-Tech, Inc. Apparatus including a sample petter tube for obtaining reproducible liquid samples of small volume
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
US4722720A (en) * 1985-04-30 1988-02-02 Nhk Spring Co., Ltd. Tension providing device
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
DE3724691C2 (de) * 1987-07-25 1999-03-18 Konrad Minninger Pharmazeutisches Mittel zur lokalen Therapie von schuppenden Hautkrankheiten
ATE91079T1 (de) * 1989-01-25 1993-07-15 Wolff Chem Pharm Gmbh Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
US5087242A (en) * 1989-07-21 1992-02-11 Iomed, Inc. Hydratable bioelectrode
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
US5087241A (en) * 1990-07-24 1992-02-11 Empi, Inc. Iontophoresis electrode with reservoir and injection site
DK0555375T3 (da) * 1990-10-29 1995-07-10 Alza Corp Iontophorerisk medicin udleveringselektrode, og fremgangsmåde til hydrering af samme
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
DE69320378T2 (de) * 1992-01-21 1999-04-29 Macrochem Corp Iontophoretische verbesserte Verabreichung von Medikamenten
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物

Also Published As

Publication number Publication date
PT789589E (pt) 2007-08-31
US5736580A (en) 1998-04-07
CA2201725A1 (en) 1996-05-23
ES2292171T3 (es) 2008-03-01
JP4049389B2 (ja) 2008-02-20
HK1000450A1 (en) 2008-04-03
JPH10508849A (ja) 1998-09-02
US5811465A (en) 1998-09-22
ATE369150T1 (de) 2007-08-15
WO1996014869A1 (en) 1996-05-23
EP0789589A1 (en) 1997-08-20
CA2201725C (en) 2008-06-03
DE69535556T2 (de) 2008-03-06
US6057374A (en) 2000-05-02
EP0789589B1 (en) 2007-08-08
DE69535556D1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
DK0789589T3 (da) Sammensætning, anordning og fremgangsmåde til elektrotransport-middeltilförsel
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
DK0796127T3 (da) Anordning til afgivelse ved elektrotransport
BR9608600A (pt) Método e aparelho de distribuição de agente por eletrotransporte
DK662887A (da) Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf
NO881292D0 (no) Fremgangsmaate og anordning til administrering av ioniserbare farmasoeytiske forbindelser gjennom huden.
ATE155045T1 (de) Vorrichtung zur verabreichung von heilmitteln
BR9506470B8 (pt) Composição adesiva sensível à pressão e sistema de distribuição transdérmica de droga.
DE69331149D1 (de) Gerät zum injizieren eines pharmazeutischen präparats in festem zustand
DK1009393T3 (da) Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning
WO2003039620A3 (en) Integrated transdermal drug delivery system
HRP931107B1 (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
EP0922467A3 (en) Iontophoretic drug delivery
DE69532477D1 (de) Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe
SE9603725D0 (sv) New teatment
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
DE3271605D1 (en) Improvements in or relating to electrotherapeutic apparatus
NZ502405A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
PL339736A1 (en) Method of protecting persons against contamination due to inadmissible oral taking toxic ingredients of a transdermal therapeutic system and transdermal therapeutic system containing a contaminating agent
ES2136605T3 (es) Dispositivo electrico de aplicacion transdermica de farmacos con un agente de contrarresto.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
SU1377019A1 (ru) Способ наложени электродов с использованием двустороннего кле щего кольца
WO2001000191A3 (en) Use of fosphenytion for the treatment of acute neuropathic pain
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.